| (USD) | Jun 2026 | Y/Y change |
|---|---|---|
| Revenue | 0.00 | — |
| Operating expense | — | — |
| Net income | -128.02M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, VKTX returned +30.3% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | -3.7% |
| 1 year | +30.3% |
| 5 years | +412.7% |
| 10 years | +2429.1% |
| All-time high | $82.00 (Mar 2024) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in VKTX would be worth today ›No. Viking Therapeutics, Inc. has not paid a dividend in the past 12 months.
Viking Therapeutics, Inc. stock trades on NASDAQ under the ticker symbol VKTX.
Viking Therapeutics, Inc. is part of the Healthcare sector.
Viking Therapeutics, Inc. has a market cap of 3.95B USD, based on the latest quote.
Viking Therapeutics, Inc. is expected to report earnings around Oct 28, 2026. That date is an estimate and has not been confirmed by the company.
